Use of proton pump inhibitors is associated with fractures in young adults: a population-based study

被引:81
|
作者
Freedberg, D. E. [1 ]
Haynes, K. [2 ]
Denburg, M. R. [3 ]
Zemel, B. S. [4 ]
Leonard, M. B. [5 ,6 ]
Abrams, J. A. [1 ]
Yang, Y. -X. [2 ,7 ]
机构
[1] Columbia Univ, Div Digest & Liver Dis, Med Ctr, New York, NY 10032 USA
[2] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Div Nephrol, Philadelphia, PA 19104 USA
[4] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[5] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA
[6] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA
[7] Univ Penn, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA
关键词
Acid suppression medications; Bone mineral density; Fracture; Histamine-2 receptor antagonists; Osteoporosis; Outcomes research; Pediatrics; Pharmacoepidemiology; Proton pump inhibitors; BONE-MINERAL DENSITY; GASTROESOPHAGEAL-REFLUX DISEASE; NETWORK THIN DATABASE; CALCIUM-ABSORPTION; RISK; CHILDREN; EPIDEMIOLOGY; VALIDATION; ACID; OSTEOPOROSIS;
D O I
10.1007/s00198-015-3168-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Summary Proton pump inhibitors (PPIs) are associated with risk for fracture in osteoporotic adults. In this population-based study, we found a significant association between PPIs and fracture in young adults, with evidence of a dose-response effect. Young adults who use PPIs should be cautioned regarding risk for fracture. Introduction Proton pump inhibitors (PPIs) are associated with fracture in adults with osteoporosis. Because PPI therapy may interfere with bone accrual and attainment of peak bone mineral density, we studied the association between use of PPIs and fracture in children and young adults. Methods We conducted a population-based, case-control study nested within records from general medical practices from 1994 to 2013. Participants were 4-29 years old with a parts per thousand yen1 year of follow-up who lacked chronic conditions associated with use of long-term acid suppression. Cases of fracture were defined as the first incident fracture at any site. Using incidence density sampling, cases were matched with up to five controls by age, sex, medical practice, and start of follow-up. PPI exposure was defined as 180 or more cumulative doses of PPIs. Conditional logistic regression was used to estimate the odds ratio and confidence interval for use of PPIs and fracture. Results We identified 124,799 cases and 605,643 controls. The adjusted odds ratio for the risk of fracture associated with PPI exposure was 1.13 (95 % CI 0.92 to 1.39) among children aged < 18 years old and 1.39 (95 % CI 1.26 to 1.53) among young adults aged 18-29 years old. In young adults but not children, we observed a dose-response effect with increased total exposure to PPIs (p for trend < 0.001). Conclusions PPI use was associated with fracture in young adults, but overall evidence did not support a PPI-fracture relationship in children. Young adults who use PPIs should be cautioned regarding potentially increased risk for fracture, even if they lack traditional fracture risk factors.
引用
收藏
页码:2501 / 2507
页数:7
相关论文
共 50 条
  • [41] Atopic eczema and fracture risk in adults: A population-based cohort study
    Lowe, Katherine E.
    Mansfield, Kathryn E.
    Delmestri, Antonella
    Smeeth, Liam
    Roberts, Amanda
    Abuabara, Katrina
    Prieto-Alhambra, Daniel
    Langan, Sinead M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : 563 - +
  • [42] Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study
    Hong, Sung-Hyun
    Lee, Eui-Kyung
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (04) : 479 - 488
  • [43] Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study
    S.-M. Lin
    S.-H. Yang
    C.-C. Liang
    H.-K. Huang
    Osteoporosis International, 2018, 29 : 153 - 162
  • [44] Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study
    Lin, S. -M.
    Yang, S. -H.
    Liang, C. -C.
    Huang, H. -K.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 (01) : 153 - 162
  • [45] Association between Daily Sunlight Exposure and Fractures in Older Korean Adults with Osteoporosis: A Nationwide Population-Based Cross-Sectional Study
    Lee, Hye Jun
    Kim, Choon Ok
    Lee, Duk Chul
    YONSEI MEDICAL JOURNAL, 2021, 62 (07) : 593 - 599
  • [46] Total Cholesterol Variability and the Risk of Osteoporotic Fractures: A Nationwide Population-Based Cohort Study
    Kim, Dongyeop
    Kim, Jee Hyun
    Song, Tae-Jin
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (03):
  • [47] The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study
    Fraser, L-A.
    Leslie, W. D.
    Targownik, L. E.
    Papaioannou, A.
    Adachi, J. D.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (04) : 1161 - 1168
  • [48] The burden of fractures in Brazil: A population-based study
    Siqueira, FV
    Facchini, LA
    Hallal, PC
    BONE, 2005, 37 (02) : 261 - 266
  • [49] Effectiveness of Bisphosphonates in Young Adults With Fragility Fractures: Representative Population-based Cohort Study
    Kong, Sung Hye
    Park, Ju-young
    Shin, Moon-Kyung
    Lee, Hyo-Jung
    Kim, Jin Woo
    Park, Seung Shin
    Kim, Sang Wan
    Shin, Chan Soo
    Song, Tae-Jin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [50] Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population--based cohort study
    Abtahi, Shahab
    Driessen, Johanna H. M.
    Burden, Andrea M.
    Souverein, Patrick C.
    van den Bergh, Joop P.
    van Staa, Tjeerd P.
    Boonen, Annelies
    de Vries, Frank
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (04) : 423 - 431